BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7050636)

  • 1. Transport mechanisms of 6-diazo-5-oxo-L-norleucine in Escherichia coli K-12.
    Williams MV
    Microbiologica; 1982 Jan; 5(1):57-61. PubMed ID: 7050636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inactivation of microbial glutamin-(asparagin-)ase by azaserine and 6-diazo-5-oxo-L-norleucine].
    Lebedeva ZI; Kabanova EA; Berezov TT
    Biull Eksp Biol Med; 1985 Dec; 100(12):696-8. PubMed ID: 4074870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-diazo-5-oxo-L-norleucine and azaserine as affinity inhibitors of glutamin(asparagin)ase.
    Lebedeva ZI; Kabanova EA; Berezov TT
    Biochem Int; 1986 Mar; 12(3):413-20. PubMed ID: 3707592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the modes of action of azaserine in Escherichia coli. Mechanism of resistance to azaserine.
    Williams MV; Rowe JJ; Kerr TJ; Tritz GJ
    Microbios; 1977; 19(77-78):181-90. PubMed ID: 362130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LIV-I/LS system as a determinant of azaserine sensitivity of Escherichia coli K-12.
    Koyanagi T; Katayama T; Suzuki H; Kumagai H
    FEMS Microbiol Lett; 2004 Aug; 237(1):73-7. PubMed ID: 15268940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
    Willis RC; Seegmiller JE
    J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of D- and L-azaserine, 6-diazo-5-oxo-L-norleucine and N-(N-methyl-N-nitroso-carbamyl)-L-ornithine in the Salmonella test system.
    Staiano N; Everson RB; Cooney DA; Longnecker DS; Thorgeirsson SS
    Mutat Res; 1980 Dec; 79(4):387-90. PubMed ID: 7003378
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
    Rosenfeld H; Roberts J
    Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolation of Pseudomonas aurantiaca strains capable of overproduction of phenazine antibiotics].
    Feklistova IN; Maksimova NP
    Mikrobiologiia; 2008; 77(2):207-12. PubMed ID: 18522322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of several glutamine antimetabolites on guaninemonophosphate synthetase of E. coli].
    Iarovaia LM; Mardashev SR; Debov SS
    Vopr Med Khim; 1967; 13(2):176-80. PubMed ID: 4876547
    [No Abstract]   [Full Text] [Related]  

  • 11. Azaserine resistance in Escherichia coli: chromosomal location of multiple genes.
    Williams MV; Kerr TJ; Lemmon RD; Tritz GJ
    J Bacteriol; 1980 Jul; 143(1):383-8. PubMed ID: 6995438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
    Huber KR; Rosenfeld H; Roberts J
    Int J Cancer; 1988 May; 41(5):752-5. PubMed ID: 3366493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the hydrolysis and the covalent binding of 6-diazo-5-oxo-L-[6-14C]norleucine by rat renal phosphate-dependent glutaminase.
    Clark VM; Shapiro RA; Curthoys NP
    Arch Biochem Biophys; 1982 Jan; 213(1):232-9. PubMed ID: 6120680
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the effects of 5-oxo-6-diazo-norleucine and albizziin on the biosynthesis of anthranilic acid in Saccharomyces cerevisiae].
    Lingens F; Lück W; Müller G
    Hoppe Seylers Z Physiol Chem; 1965; 343(4):282-9. PubMed ID: 5328312
    [No Abstract]   [Full Text] [Related]  

  • 15. Inactivation of renal gamma-glutamyl transferase by 6-diazo-5-oxo-L-norleucylglycine, an inactive precursor of affinity-labeling reagent.
    Inoue M; Morino Y
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):46-9. PubMed ID: 6113588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site.
    Shapiro RA; Clark VM; Curthoys NP
    J Biol Chem; 1979 Apr; 254(8):2835-8. PubMed ID: 429321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YddG from Escherichia coli promotes export of aromatic amino acids.
    Doroshenko V; Airich L; Vitushkina M; Kolokolova A; Livshits V; Mashko S
    FEMS Microbiol Lett; 2007 Oct; 275(2):312-8. PubMed ID: 17784858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a mutant Chinese hamster cell line resistant to the glutamine analog 6-diazo-5-oxo-L-norleucine.
    Kaufman ER
    Somat Cell Mol Genet; 1985 Jan; 11(1):1-10. PubMed ID: 3856328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DON, CONV and DONV-III. Pharmacologic and toxicologic studies.
    Cooney DA; Jayaram HN; Milman HA; Homan ER; Pittillo R; Geran RI; Ryan J; Rosenbluth RJ
    Biochem Pharmacol; 1976 Aug; 25(16):1859-70. PubMed ID: 9092
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
    Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
    J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.